Stay updated on KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Sign up to get notified when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.

Latest updates to the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page
- Check7 days agoChange DetectedDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.4%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check64 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study information about belumosudil (KD025) for treating diffuse cutaneous systemic sclerosis, while adding new identifiers and a revision note.SummaryDifference10%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.